Pancreatic Cancer Research

ResearcherWellcome Sanger InstituteNo recent work listed

Mathew J. Garnett

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2618-4237; OpenAlex author ID A5085472676. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Effective drug combinations in breast, colon and pancreatic cancer cells. Last author DOI 10.1038/s41586-022-04437-2↗
  2. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Co-author DOI 10.1073/pnas.1911273116↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patricia Jaaks · 1 shared paper, 2022 · strength 0.11
  2. Else Driehuis · 1 shared paper, 2019 · strength 0.07
  3. Sylvia F. Boj · 1 shared paper, 2019 · strength 0.07
  4. G. Johan A. Offerhaus · 1 shared paper, 2019 · strength 0.07
  5. Lodewijk A.A. Brosens · 1 shared paper, 2019 · strength 0.07
  6. Hans C. Clevers · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.